IL6 and prostate carcinoma: Given that IL-6 is exclusively produced in CAFs and not resting fibroblasts, it has been suggested that CAF-derived IL-6 may stimulate VEGF secretion from prostate cancer cells independently of AR signaling via PI3K/AKT, STAT3 and MAPK signaling [191,228].